Vaqta Related Published Studies
Well-designed clinical trials related to Vaqta (Hepatitis A Vaccine)
Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens. [2011.04]
Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers. [2011.04]
Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years. [2011.03]
The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination. [2011.02]
A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients. [2010.10]
Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents. [2010.08.23]
Predictors of hepatitis knowledge improvement among methadone maintained clients enrolled in a hepatitis intervention program. [2010.08]
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. [2010.06.17]
Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States. [2010.06]
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. [2009.07.16]
Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults. [2009.01]
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study. [2008.11.01]
[Immunogenicity and safety of three consecutive lots on an inactivated hepatitis A vaccine: a double-blind, immunogenicity and safety of three consecutive lots on a inactivated hepatitis A vaccine:a double-blind, randomized and controlled trial in children] [2008.06]
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41. [2008.05]
Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. [2008.05]
Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial. [2008.04.24]
Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents. [2008.03.25]
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. [2008.03.04]
Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines. [2008.01.30]
Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth. [2008.01.30]
One arm or two? Concurrent administration of meningococcal C conjugate and hepatitis B vaccines in pre-teens. [2008.01]
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. [2007.12.12]
Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer. [2007.12]
Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. [2007.11]
Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. [2007.10.25]
Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine. [2007.10]
Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant. [2007.10]
Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study. [2007.10]
Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial. [2007.09]
Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. [2007.09]
Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure. [2007.09]
Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years. [2007.08]
Cellular and humoral immune response to a third generation hepatitis B vaccine. [2007.08]
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. [2007.08]
Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. [2007.07]
Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. [2007.06.14]
Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults. [2007.05]
Vitamin A Supplementation Enhances Infants' Immune Responses to Hepatitis B Vaccine but Does Not Affect Responses to Haemophilus influenzae Type b Vaccine. [2007.05]
Safety and efficacy of a recombinant hepatitis E vaccine. [2007.03.01]
Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules. [2007.01.02]
Rapid and sustained immune response against hepatitis a and B achieved with combined vaccine using an accelerated administration schedule. [2007.01]
Predisposing, reinforcing and enabling factors associated with hepatitis B testing in Chinese Canadians in British Columbia. [2007.01]
Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients. [2007]
Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. [2006.06.29]
Interchangeability of Hepatitis A boosters, Avaxim and Vaqta, in healthy adults following a primary dose of the combined typhoid/Hepatitis A vaccine Viatim. [2006.05.15]
Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines. [2006.05.15]
Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks. [2006]
Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years. [2005.11]
Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. [2005.10.17]
A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. [2005.04.22]
Interchangeability and tolerability of a virosomal and an aluminum-adsorbed hepatitis A vaccine. [2005.03.31]
Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults. [2004.11.15]
A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults. [2004.07]
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. [2004.03]
Simultaneous vaccination against hepatitis A and B: results of an open, randomized study from the occupational health point of view. [2004]
A combined dual-chamber typhoid/hepatitis A vaccine as a booster dose in hepatitis A primed adults. [2003.12.01]
Immunogenicity and safety of two doses of a paediatric hepatitis A vaccine in thai children: comparison of three vaccination schedules. [2003.12]
[The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children] [2003.11]
[Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents.] [2003.10]
Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies. [2003.09.08]
Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. [2003.09.01]
Hepatitis A and B vaccination in a sexually transmitted disease clinic for men who have sex with men. [2003.09]
Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease. [2003.09]
Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial. [2003.04.15]
Immunogenicity and safety of a new inactivated hepatitis A vaccine in young adults: a comparative study. [2002.10]
Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years. [2002.06.07]
Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in healthy Chilean subjects. [2002.06]
[Immunogenicity and efficacy of two live attenuated hepatitis A vaccines (H(2) strains and LA-1 strains)] [2002.05.25]
Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix in healthy Indian children. [2002.05.15]
Combined vaccination against hepatitis A, hepatitis B, and typhoid fever: safety, reactogenicity, and immunogenicity. [2002.05]
An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines. [2002.03]
A new accelerated vaccination schedule for rapid protection against hepatitis A and B. [2002.01.15]
A two-dose combined vaccine against hepatitis A and hepatitis B in healthy children and adolescents compared to the corresponding monovalent vaccines. [2002.01]
[Safety and immunogenicity of a new inactivated hepatitis A vaccine] [2001.12]
[A field evaluation of the epidemiological efficacy of an attenuated live hepatitis A vaccine (H2 strain)] [2001.11]
Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study. [2001.09.14]
A randomized study of a flexible booster dosing regimen of VAQTA in adults: safety, tolerability, and immunogenicity. [2001.09.14]
A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. [2001.09.14]
A randomised comparison of two inactivated hepatitis A vaccines, Avaxim and Vaqta, given as a booster to subjects primed with Avaxim. [2001.08.14]
Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix. [2001.02.01]
Randomized controlled trial of concurrent hepatitis A and B vaccination. [2001.02]
Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix. [2000.12.08]
Different HBs antibody versus lymphoproliferative responses after application of a monovalent (hepatitis B) or combined (hepatitis A + hepatitis B) vaccine. [2000.12]
Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines. [2000.11.22]
Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults. [2000.10.15]
A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity. [2000.09]
Dose range evaluation of a new inactivated hepatitis A vaccine administered as a single dose followed by a booster. [2000.08.15]
[Primary study on immunologic effect of live attenuated hepatitis A vaccine (H2 strain) after booster dose] [2000.04]
Hepatitis A vaccine administration: comparison between jet-injector and needle injection. [2000.03.17]
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia. [2000.03]
Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. [2000.01.06]
[Further survey on efficacy of attenuated live hepatitis A vaccines] [2000.01]
Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years. [1999.12]
Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. [1999.12]
A two dose combined hepatitis A and B vaccine in Chinese youngsters. [1999.09]
Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults. [1999.05.04]
Comparative immunogenicity and tolerance of Vaqta and Havrix. [1999.04.23]
Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. [1999.04.03]
Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults. [1999.03.17]
Hepatitis A vaccine in healthy adults: a comparison of immunogenicity and reactogenicity between two- and three-dose regimens. [1999.01]
Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM). [1998.12]
|